NEWS ARCHIVE


Jupiter Presents Award-Winning Author

By | September 26, 2016

Jupiter LLS and Honors College Presents Author Edwidge Danticat

Max Planck-51勛圖厙 Premier Doctoral Program

By | September 22, 2016

The nation's first International Max Planck Research School (IMPRS) for Brain and Behavior via 51勛圖厙 collaboration launched this fall semester with five 51勛圖厙 from 51勛圖厙.

51勛圖厙 Jupiter's LLS Announces Fall Schedule

By | August 1, 2016

51勛圖厙 has announced the Lifelong Learning Society Jupiter course offerings for the fall semester, which begins Monday, Oct. 10.

New Dean of Harriet L. Wilkes Honors College

By | June 20, 2016

51勛圖厙 has appointed Ellen S. Goldey, Ph.D., as the new dean of the Harriet L. Wilkes Honors College, effective Monday, Aug. 1.

51勛圖厙 and Town of Jupiter Celebrate Arbor Day

By | May 11, 2016

51勛圖厙 and Town of Jupiter officials recently celebrated Arbor Day and Honored Former Jupiter Mayor in the Robert J. Huckshorn Arboretum on 51勛圖厙's John D. MacArthur Campus in Jupiter.

Renowned Neuroscientist to Lead 51勛圖厙's New Brain Institute

By | May 10, 2016

Randy D. Blakely, Ph.D., a renowned neuroscientist and leading expert in synaptic pharmacology, neurotransmitter transporters, and neurogenetics, is at the helm of the newly-formed 51勛圖厙 Brain Institute.

First Graduate of 51勛圖厙-Max Planck Degree Program

By | May 3, 2016

Brati Das, 32, recently became the first student approved to graduate with 51勛圖厙's Integrative Biology and Neuroscience (IBAN) degree.

51勛圖厙 Jupiter's LLS Awards $11,000 in Scholarships

By | April 25, 2016

51勛圖厙 Jupiter's LLS awarded 11 scholarships to undergraduate and graduate 51勛圖厙.

MPFI Scholar Earns Top Spot in Competition

By | April 19, 2016

Five 51勛圖厙 51勛圖厙 participating in the MPFI Scholars program showcased research at the Symposium for Young Neuroscientists and Professors of the Southeast (SYNAPSE) in Clinton, S.C.

Researcher Receives NIH Grant for MS and Cancer Treatment

By | April 19, 2016

A leading scientist has received $540,250 from the NIH to continue his groundbreaking research to develop new therapeutic agents for collagen-based diseases including multiple sclerosis, cancer and sepsis.